Chien-Tsun Kuan

President/CEO and Co-Founder
ARCE Therapeutics, Inc.
​
​​

Dr. Chien-Tsun Kuan, President / CEO and co-Founder, is leading ARCE Therapeutics, Inc., a discovery to clinical stage company developing new generation cell & gene therapies such as CAR-engineered cells, for cancer treatment, including liquid, solid tumors, and immunological disorder diseases.  Prior to his current position, he was EVP/ COO & CTO of GenomeFrontier Therapeutics, Inc. that he was responsible for guiding the research and development of the company’s pipeline assets as well as the business operation. Prior to this position, Dr. Kuan was Deputy Executive Director of Institute of Biologics at Development Center for Biotechnology in Taipei, Taiwan, where he lead research and development of therapeutic antibodies, protein fusions, and cellular gene therapy for the treatment of cancer, autoimmune, neurodegenerative and infectious diseases. Earlier, Dr. Kuan was a professor at Duke University Medical Center, leading the Antibody Engineering and Antibody Therapeutics Program in the Preston Robert Tisch Brain Tumor Center at Duke to translate the laboratory results to clinical trials in cancer patients.
 

Speech title & Synopsis

Opening Remarks

.